Please assess the completion status of the following clinical trial:

Trial Title: txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~Participants must:~1. Be male (sex at birth and gender identity)~2. Self-identify as gay, bisexual, or queer; ever had sex with a man; or be physically attracted to men~3. Be English speaking~4. Live in the Chicago metro area~5. Be the exclusive owner of a cell phone~6. Have used text messaging for at least 6 months~7. Plan to have the same cell phone number for the next 9 months~8. Be enrolled in an unlimited text messaging plan~Exclusion Criteria~* Participants must not have been previously vaccinated for HPV.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 25 Years
- Healthy Volunteers: t

Study Arms:
- txt2protect (Type: EXPERIMENTAL): Content was delivered in 2 phases over 36 weeks. During Phase 1 (weeks 1-3), participants received 10-12 messages daily. During Phase 2 (weeks 4-36), message frequency decreased to monthly messages. Phase 1 content was presented in 3 modules. Module 1 addressed information about HPV infection and HPV vaccination. Module 2 addressed motivation to receive HPV vaccine. Module 3 addressed behavioral skills and self-efficacy for initiating and completing the 3-dose series (e.g., talking with their doctor about the vaccine). Phase 2 booster messages largely reinforced Phase 1 content to foster continued engagement with the program.~txt2protect: Text messages sharing HIV/STI prevention information with a focus on HPV infection and vaccination.
- Sexual Health Control (Type: ACTIVE_COMPARATOR): Content was delivered in 2 phases over 36 weeks. During Phase 1 (weeks 1-3), participants received 10-12 messages daily. During Phase 2 (weeks 4-36), message frequency decreased to monthly messages. Phase 1 content was presented in 3 modules; however, unlike the treatment group, content was topic-based rather than theory-based and focused on general sexual health. Module 1 addressed basic facts about HIV and sexually transmitted infections (STI), including HPV. Module 2 addressed HIV/STI prevention (e.g., condom use, PrEP) and will included basic facts about HPV vaccination currently available online. Module 3 addressed tips for healthy relationships. Phase 2 booster messages largely reinforced Phase 1 content to foster continued engagement with the program.~Sexual Health Control: Text messages sharing HIV/STI prevention and healthy relationship building information, including information about HPV infection and vaccination.

Based on this trial design, predict the completion outcome and termination type (if applicable).